纳米载体
医学
背景(考古学)
肺癌
慢性阻塞性肺病
药物输送
肺病
遗传增强
药品
靶向给药
小干扰RNA
哮喘
疾病
生物信息学
免疫学
药理学
基因
病理
生物
纳米技术
核糖核酸
内科学
遗传学
古生物学
材料科学
作者
Venkateshwaran Krishnaswami,Ruckmani Kandasamy
标识
DOI:10.2174/1381612828666220727144223
摘要
The importance of siRNA in nano drug delivery systems to target important pulmonary disorders, such as chronic obstructive pulmonary disease (COPD), asthma, lung cancer, and others, is reviewed in this perspective. The great majority of lung illnesses are caused by protein misfolding. As a result, siRNA-based therapies are increasingly being used to target the gene. Given the difficulties of delivering bare siRNA, siRNA protection may ensure its efficacy in gene therapy. These issues could be solved with a nano-based siRNA delivery systems. In this context, a siRNA-based nanocarrier for major pulmonary disorders has been explored.
科研通智能强力驱动
Strongly Powered by AbleSci AI